SILKWAVE INC (00471): Oversubscription rate of 4.68% for the rights issue.
China Broadcasting Corporation (00471) announced that the rights issue will become unconditional on February 3, 2026 (Tuesday), and the deadline for acceptance is 4:00 pm on February 23, 2026 (Monday). A total of 4 valid acceptances were received for a total of 255 million shares allocated for the rights issue, equivalent to approximately 70.90% of the total number of shares available for subscription under the rights issue; and a total of 4 valid acceptances were received for an additional 122 million shares, equivalent to approximately 33.78% of the total number of shares available for subscription under the rights issue.
SILKWAVE INC (00471) announced that the rights issue will become unconditional on February 3, 2026 (Tuesday), with the deadline for acceptance being 4:00 pm on February 23, 2026 (Monday). A total of 4 valid acceptances for a total of 255 million shares of the rights issue shares have been received, representing approximately 70.90% of the total number of 359.8 million shares available for subscription under the rights issue. Additionally, a total of 4 valid acceptances for an additional 122 million shares of the rights issue shares have been received, representing approximately 33.78% of the total number of rights issue shares available for subscription.
A total of 8 valid acceptances and applications for 377 million shares of the rights issue shares have been received, representing approximately 104.68% of the maximum number of 359.8 million shares of rights issue shares offered for subscription.
Based on the above results, there is an oversubscription of 16.85 million shares of rights issue shares, representing approximately 4.68% of the maximum number of 359.8 million shares of rights issue shares offered for subscription. The net proceeds from the rights issue are approximately HK$162 million.
Related Articles

Jiangsu Aidea Pharmaceutical Group (688488.SH) plans to raise no more than 1.277 billion yuan through a private placement.

SAP (SAP.US) restructuring board of directors: CEO Krayan hands over sales power, All in AI prepares to face the wave of technological disruption.

Shaanxi Beiyuan Chemical Industry Group (601568.SH): Hengyuan Investment plans to reduce its shareholding by no more than 2%.
Jiangsu Aidea Pharmaceutical Group (688488.SH) plans to raise no more than 1.277 billion yuan through a private placement.

SAP (SAP.US) restructuring board of directors: CEO Krayan hands over sales power, All in AI prepares to face the wave of technological disruption.

Shaanxi Beiyuan Chemical Industry Group (601568.SH): Hengyuan Investment plans to reduce its shareholding by no more than 2%.

RECOMMEND





